Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Silke

Showing results (41-50 of 199) with videos related to

Pageof 20
Sort By:
Nature Immunology|July 22, 2015
Erratum: The diverse role of RIP kinases in necroptosis and inflammationJohn Silke, James A Rickard, Motti Gerlic
Nature Reviews. Rheumatology|July 10, 2020
Cell death in chronic inflammation: breaking the cycle to treat rheumatic diseaseHolly Anderton, Ian P Wicks, John Silke
Trends in Molecular Medicine|February 16, 2017
'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid LeukemiaGabriela Brumatti, Najoua Lalaoui, Andrew H Wei, et al.
The Journal of General Virology|September 20, 2000
Characterization of the ectromelia virus serpin, SPI-2Stephen J Turner, John Silke, Bronwyn Kenshole, et al.
Nature Reviews. Cancer|March 7, 2024
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunityPascal Meier, Arnaud J Legrand, Dieter Adam, et al.
Immunology and Cell Biology|October 9, 2013
Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1Nima Etemadi, Andrew Webb, Aleksandra Bankovacki, et al.
Frontiers in Immunology|July 18, 2022
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric CancersYanhong Ni, Jun T Low, John Silke, et al.
Trends in Immunology|November 9, 2021
Unleashing TNF cytotoxicity to enhance cancer immunotherapyAndrew J Freeman, Conor J Kearney, John Silke, et al.
Blood Cells, Molecules & Diseases|May 16, 2008
Lack of reproducible growth inhibition by Schlafen1 and Schlafen2 in vitroLiang Zhao, Brent Neumann, Kathleen Murphy, et al.
Nature|August 24, 2012
Is BID required for NOD signalling?Ueli Nachbur, James E Vince, Lorraine A O'Reilly, et al.
Pageof 20

Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Nature Immunology|July 22, 2015
Erratum: The diverse role of RIP kinases in necroptosis and inflammationJohn Silke, James A Rickard, Motti Gerlic
Nature Reviews. Rheumatology|July 10, 2020
Cell death in chronic inflammation: breaking the cycle to treat rheumatic diseaseHolly Anderton, Ian P Wicks, John Silke
Trends in Molecular Medicine|February 16, 2017
'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid LeukemiaGabriela Brumatti, Najoua Lalaoui, Andrew H Wei, et al.
The Journal of General Virology|September 20, 2000
Characterization of the ectromelia virus serpin, SPI-2Stephen J Turner, John Silke, Bronwyn Kenshole, et al.
Nature Reviews. Cancer|March 7, 2024
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunityPascal Meier, Arnaud J Legrand, Dieter Adam, et al.
Immunology and Cell Biology|October 9, 2013
Progranulin does not inhibit TNF and lymphotoxin-α signalling through TNF receptor 1Nima Etemadi, Andrew Webb, Aleksandra Bankovacki, et al.
Frontiers in Immunology|July 18, 2022
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric CancersYanhong Ni, Jun T Low, John Silke, et al.
Trends in Immunology|November 9, 2021
Unleashing TNF cytotoxicity to enhance cancer immunotherapyAndrew J Freeman, Conor J Kearney, John Silke, et al.
Blood Cells, Molecules & Diseases|May 16, 2008
Lack of reproducible growth inhibition by Schlafen1 and Schlafen2 in vitroLiang Zhao, Brent Neumann, Kathleen Murphy, et al.
Nature|August 24, 2012
Is BID required for NOD signalling?Ueli Nachbur, James E Vince, Lorraine A O'Reilly, et al.
Pageof 20